MASTER MANUFACTURING SUPPLY AGREEMENTMaster Manufacturing Supply Agreement • November 5th, 2020 • Retrophin, Inc. • Pharmaceutical preparations
This Master Manufacturing Supply Agreement is made effective as of September 30, 2020 (the “Effective Date”) and is between Retrophin, Inc., a Delaware corporation located at 3721 Valley Centre Drive, Suite 200, San Diego, CA 92130, USA (“Client”) and STA Pharmaceutical Hong Kong Limited, a Hong Kong corporation located at [***]1 (“Supplier”), acting on behalf of itself and its Affiliates, together with the Client, the “Parties,” and each, a “Party.”
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. FIRST AMENDMENT TO MASTER MANUFACTURING SUPPLY AGREEMENTMaster Manufacturing Supply Agreement • February 23rd, 2023 • Travere Therapeutics, Inc. • Pharmaceutical preparations
This First Amendment (the “Amendment”), effective as of the November 14, 2022 (“Amendment Effective Date”), is made by and between Travere Therapeutics, Inc. (formerly known as Retrophin, Inc.) (“Client”), and STA Pharmaceutical Hong Kong Limited (“Supplier”). Client and Supplier may be hereinafter referred to individually as a “Party” and collectively as the “Parties.”
